Psyomics

Mental Health CareEngland, United Kingdom11-50 Employees

Psyomics develops a digital platform designed to transform how mental health care is assessed, triaged, and treated. The system captures dynamic patient-reported information to shorten triage and assessment times, and it began offering support for more than 15 mental health conditions in late 2022, with over 8,500 patients served. The company originated as a Cambridge University biotech spinout and is led by CEO Dr Melinda Rees, with founder Professor Sabine Bahn; it is based in Cambridge, England.

Psyomics operates within the mental health care technology space, focusing on health services and providers seeking faster access to mental health support and lighter clinician workloads. It has established partnerships with NHS Trusts, including North London NHS Foundation Trust to improve access for residents across Barnet, Camden, Enfield, Haringey, and Islington, announced in October 2025, and a May 2026 collaboration with Derbyshire Healthcare NHS Foundation Trust to expand the platform in community services.

Sign up for free to view info

Email Format Employee directory